Mitoxantrone Terminated Phase 2 Trials for Leukemia Acute Myeloid Leukemia (AML) / High-risk Myelodysplastic Syndrome (MDS) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02198482Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)